Henry Schein (NASDAQ:HSIC) advanced 5.3% following a 3.3% increase on Friday amid some speculation the dental products ...

Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Activist Ananym Capital Management is urging Henry Schein (HSIC) to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business, Svea Herbst-Bayliss ...

Dental care supplier Henry Schein advanced in Monday trading as investors bet that Robert F. Kennedy Jr., President-elect ...

Dental care supplier Henry Schein advanced in Monday trading as investors bet that Robert F. Kennedy Jr., President-elect ...

Robert F. Kennedy's Jr. push to remove fluoride from the nation's public water supply could benefit some companies. Here's ...

The most recent earnings report from Henry Schein, Inc. (NASDAQ:HSIC) was disappointing for shareholders. However, our analysis suggests that the soft headline numbers are getting counterbalanced by ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...

Nov 5 (Reuters) - Dental products distributor Henry Schein (HSIC.O), opens new tab beat third-quarter profit estimates on Tuesday, as a series of cost-saving measures helped counter tepid demand and ...

Henry Schein ( (HSIC) ) has released its Q3 earnings. Here is a breakdown of the information Henry Schein presented to its investors. Henry ...